Research Study Evaluating Cinacalcet for Patients With End Stage Renal Disease (ESRD)
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to observe the effects of a treatment strategy that incorporates
cinacalcet HCl into the management of secondary hyperparathyroidism (HPT) in subjects with
ESRD receiving hemodialysis, on bio-intact parathyroid hormone (biPTH), corrected serum
calcium, serum phosphorus, and calcium phosphorus product.